Literature DB >> 9415040

Augmentation of monocyte chemotactic protein-1 and mRNA transcript in chronic inflammatory states induced by potassium permanganate (KMnO4) in vivo.

P Conti1, M Reale, C Feliciani, S Frydas, M Trakatellis, F C Placido, I Cataldo, M Di Gioacchino, R C Barbacane.   

Abstract

Monocyte chemotactic protein-1 (MCP-1) is a proinflammatory cytokine that attracts and activates specific types of leucocytes. The purpose of this work was to analyse the generation of MCP-1 and mRNA transcript in a model of chronic inflammation using a granulomatous tissue induced by potassium permanganate (KMnO4; water soluble crystals). The data presented here shows that MCP-1 is generated in granuloma tissue and its level was strongly increased by i.p. injections of lipopolysaccharide (LPS) and inhibited in rats treated with injections of dexamethasone, 18 hr before the animals were killed. In histological studies LPS and dexamethasone increased and decreased, respectively, the recruitment of mononuclear cells in the granuloma tissue compared with the control granulomas from phosphate-buffered saline (PBS)-treated animals. Reverse transcriptase-polymerase chain reaction (RT-PCR) was used for mRNA extraction and cDNA synthesis. mRNA MCP-1 was significantly produced in the granuloma tissue of untreated animals, an effect increased by LPS and inhibited by dexamethasone, compared with the controls. Moreover, MCP-1 protein was found in the supernatant from homogenized granuloma tissues and the levels of MCP-1 were higher in the LPS-treated animals, while they were lower in the dexamethasone group, compared with the granulomas from the PBS-treated groups (control). The generation of MCP-1 was also found in minced granuloma tissue incubated for 18 hr (overnight) from treated (LPS or dexamethasone) and untreated (PBS) rats. When LPS was added in vitro for 18 hr to the controls and treated animals the production of MCP-1 was further increased except in the dexamethasone group (P > 0.05). Analysing blood serum from LPS, dexamethasone or PBS-treated rats, we found that MCP-1 was also present. The level was higher in the LPS group and lower in the dexamethasone group, compared with the control (PBS). In these studies we show for the first time that MCP-1 transcript and translation is generated in chronic experimental inflammatory tissue, an effect inhibited by dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9415040      PMCID: PMC1364072          DOI: 10.1046/j.1365-2567.1997.00329.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  24 in total

Review 1.  CC chemokines in allergic inflammation.

Authors:  M Baggiolini; C A Dahinden
Journal:  Immunol Today       Date:  1994-03

2.  A sensitive ELISA for the detection of human monocyte chemoattractant protein-1 (MCP-1).

Authors:  H L Evanoff; M D Burdick; S A Moore; S L Kunkel; R M Strieter
Journal:  Immunol Invest       Date:  1992-02       Impact factor: 3.657

3.  Rapid induction of arachidonic acid release by monocyte chemotactic protein-1 and related chemokines. Role of Ca2+ influx, synergism with platelet-activating factor and significance for chemotaxis.

Authors:  M Locati; D Zhou; W Luini; V Evangelista; A Mantovani; S Sozzani
Journal:  J Biol Chem       Date:  1994-02-18       Impact factor: 5.157

4.  Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant.

Authors:  M W Carr; S J Roth; E Luther; S S Rose; T A Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

5.  Inhibition of granuloma formation induced by potassium permanganate in the mouse by a specific human recombinant receptor antagonist for interleukin-1 (hrIL-1ra).

Authors:  P Conti; M R Panara; S Fridas; R C Barbacane; A Grilli; F C Placido; M Reale; S Fiore
Journal:  Cell Immunol       Date:  1993-04-01       Impact factor: 4.868

6.  Interleukin-1 receptor antagonist inhibits calcium accumulation in in vivo chronic granuloma induced by potassium permanganate.

Authors:  P Conti; M Reale; M R Panara; S Fridas; F C Placido; R C Barbacane
Journal:  Calcif Tissue Int       Date:  1993-04       Impact factor: 4.333

Review 7.  Properties of the novel proinflammatory supergene "intercrine" cytokine family.

Authors:  J J Oppenheim; C O Zachariae; N Mukaida; K Matsushima
Journal:  Annu Rev Immunol       Date:  1991       Impact factor: 28.527

8.  Production of TNF-alpha and TNF-beta by staphylococcal enterotoxin A activated human T cells.

Authors:  H Fischer; M Dohlsten; U Andersson; G Hedlund; P Ericsson; J Hansson; H O Sjögren
Journal:  J Immunol       Date:  1990-06-15       Impact factor: 5.422

9.  Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family.

Authors:  J Van Damme; P Proost; J P Lenaerts; G Opdenakker
Journal:  J Exp Med       Date:  1992-07-01       Impact factor: 14.307

10.  Formation of eosinophilic and monocytic intradermal inflammatory sites in the dog by injection of human RANTES but not human monocyte chemoattractant protein 1, human macrophage inflammatory protein 1 alpha, or human interleukin 8.

Authors:  R Meurer; G Van Riper; W Feeney; P Cunningham; D Hora; M S Springer; D E MacIntyre; H Rosen
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more
  2 in total

1.  Localized delivery of dexamethasone-21-phosphate via microdialysis implants in rat induces M(GC) macrophage polarization and alters CCL2 concentrations.

Authors:  Geoffrey D Keeler; Jeannine M Durdik; Julie A Stenken
Journal:  Acta Biomater       Date:  2014-10-25       Impact factor: 8.947

2.  Vitamin B6-deficient diet plus 4-deoxypyridoxine (4-DPD) reduces the inflammatory response induced by T. spiralis in diaphragm, masseter and heart muscle tissue of mice.

Authors:  S Frydas; N Papaioanou; I Vlemmas; I Theodoridis; G Anogiannakis; D Vacalis; A Trakatellis; R C Barbacane; M Reale; P Conti
Journal:  Mol Cell Biochem       Date:  1999-07       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.